Novo Holdings A/S 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-31 4:28 pm Sale |
2022-01-28 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 78,000 4.900% |
-26,583 (-25.42%) |
Filing |
| 2021-06-21 4:30 pm Unchanged |
2021-06-17 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 104,583 7.500% |
0 (Unchanged) |
Filing |
| 2020-10-22 4:31 pm Purchase |
2020-10-15 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 104,583 7.700% |
104,583 (New Position) |
Filing |